Biomarkers for MDM2 inhibitors for use in treating disease

Details for Australian Patent Application No. 2011237782 (hide)

Owner The Regents of the University of Michigan

Inventors Wang, Shaomeng; Malek, Sami; Long, Jianting; Ouillette, Peter

Agent Watermark

Pub. Number AU-A-2011237782

PCT Pub. Number WO2011/127058

Priority 61/322,592 09.04.10 US; 61/451,956 11.03.11 US

Filing date 5 April 2011

Wipo publication date 13 October 2011

International Classifications

A61K 31/404

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 35/00 Antineoplastic agents

A61P 35/02 Antineoplastic agents

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/127058 Priority application(s): WO2011/127058

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237787-Insertion detector for a medical probe

2011237762-Refrigeration oil and compositions with carbon dioxide refrigerant